U.S. markets closed

Bayer Aktiengesellschaft (BAYRY)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
15.69-0.20 (-1.26%)
At close: 3:59PM EDT
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close15.89
Bid0.00 x 0
Ask0.00 x 0
Day's Range15.41 - 15.69
52 Week Range12.55 - 21.59
Avg. Volume398,548
Market Cap61.529B
Beta (5Y Monthly)1.23
PE Ratio (TTM)8.51
EPS (TTM)1.84
Earnings DateN/A
Forward Dividend & Yield0.76 (4.79%)
Ex-Dividend DateApr 29, 2020
1y Target Est22.84
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
View more
  • Bayer resolves more Roundup cases, judge keeps pause on litigation

    Bayer resolves more Roundup cases, judge keeps pause on litigation

    Ken Feinberg, who is mediating talks, said his "optimism knows no bounds," and that he expected the next set of cases scheduled for trial to soon settle. U.S. District Judge Vince Chhabria in San Francisco kept a stay on litigation until Nov. 2 and asked the parties for a status update at that time. Bayer, which acquired Roundup with its purchase of Monsanto for $63 billion in 2018, agreed in June to pay around $11 billion to settle the lawsuits, which have pummeled the company's share price.

  • Moody's

    Bayer US Finance II LLC -- Moody's announces completion of a periodic review of ratings of Bayer AG

    Moody's Investors Service ("Moody's") has completed a periodic review of the ratings of Bayer AG and other ratings that are associated with the same analytical unit. The review was conducted through a portfolio review in which Moody's reassessed the appropriateness of the ratings in the context of the relevant principal methodology(ies), recent developments, and a comparison of the financial and operating profile to similarly rated peers.

  • 3 Top Value Stocks to Buy Right Now
    Motley Fool

    3 Top Value Stocks to Buy Right Now

    Three of the cheapest stocks right now are an ad-tech company, a healthcare conglomerate, and a pharmacy giant. Let's take a look at why they are ideal choices for value investors. One of the cheapest stocks in the entire tech sector is French ad-tech company Criteo (NASDAQ: CRTO).